Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Ottum S, Sethi N, Bellone S, Demirkiran C, et al. Preclinical activity of tisotumab vedotin, an antibody-drug conjugate targeting tissue factor, in uterine serous carcinoma. Gynecol Oncol 2026;211:191-199.
PMID: 42456482


Privacy Policy